Smith PH - Search Results

1

Soluble forms of the adhesion molecule E-cadherin in urine.

Banks RE, Porter WH, Whelan P, Smith PH, Selby PJ. Banks RE, et al. Among authors: smith ph. J Clin Pathol. 1995 Feb;48(2):179-80. doi: 10.1136/jcp.48.2.179. J Clin Pathol. 1995. PMID: 7745120 Free PMC article.

2

Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer.

Protheroe AS, Banks RE, Mzimba M, Porter WH, Southgate J, Singh PN, Bosomworth M, Harnden P, Smith PH, Whelan P, Selby PJ. Protheroe AS, et al. Among authors: smith ph. Br J Cancer. 1999 Apr;80(1-2):273-8. doi: 10.1038/sj.bjc.6690351. Br J Cancer. 1999. PMID: 10390008 Free PMC article.

3

Multi-centre phase II study of low dose intravesical epirubicin in the treatment of superficial bladder cancer. Yorkshire and Scottish Urological Cancer Research Groups.

Whelan P, Cumming JA, Garvie WH, Hargreave TB, Kirk D, Newling DW, Robinson MR, Smith PH. Whelan P, et al. Among authors: smith ph. Br J Urol. 1991 Jun;67(6):600-2. doi: 10.1111/j.1464-410x.1991.tb15223.x. Br J Urol. 1991. PMID: 2070204 Clinical Trial.

4

Early catheter removal following transurethral prostatectomy--impact on length of hospital stay.

Koh KB, MacDermott JP, Smith PH, Whelan P. Koh KB, et al. Among authors: smith ph. Br J Urol. 1994 Jul;74(1):61-3. doi: 10.1111/j.1464-410x.1994.tb16548.x. Br J Urol. 1994. PMID: 7519114 Clinical Trial.

5

The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up.

Tolley DA, Parmar MK, Grigor KM, Lallemand G, Benyon LL, Fellows J, Freedman LS, Grigor KM, Hall RR, Hargreave TB, Munson K, Newling DW, Richards B, Robinson MR, Rose MB, Smith PH, Williams JL, Whelan P. Tolley DA, et al. Among authors: smith ph. J Urol. 1996 Apr;155(4):1233-8. J Urol. 1996. PMID: 8632538 Clinical Trial.

6

Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours.

Hetherington JW, Newling DW, Robinson MR, Smith PH, Adib RS, Whelan P. Hetherington JW, et al. Among authors: smith ph. Br J Urol. 1987 Mar;59(3):239-41. doi: 10.1111/j.1464-410x.1987.tb04614.x. Br J Urol. 1987. PMID: 3105631

7

Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center.

Denis LJ, Keuppens F, Smith PH, Whelan P, de Moura JL, Newling D, Bono A, Sylvester R. Denis LJ, et al. Among authors: smith ph. Eur Urol. 1998;33(2):144-51. doi: 10.1159/000019546. Eur Urol. 1998. PMID: 9519355 Clinical Trial.

8

Cavitating pulmonary metastases from superficial transitional cell carcinoma of urinary bladder. Case report.

Koh KB, Rogawski K, Smith PH. Koh KB, et al. Among authors: smith ph. Scand J Urol Nephrol. 1994 Jun;28(2):201-2. doi: 10.3109/00365599409180502. Scand J Urol Nephrol. 1994. PMID: 7939475

9

Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma.

Debruyne FM, Denis L, Lunglmayer G, Mahler C, Newling DW, Richards B, Robinson MR, Smith PH, Weil EH, Whelan P. Debruyne FM, et al. Among authors: smith ph. J Urol. 1988 Oct;140(4):775-7. doi: 10.1016/s0022-5347(17)41809-x. J Urol. 1988. PMID: 2971119

10

Hemotherapy--oncological checkmate or surgical aid?

Smith PH. Smith PH. Prog Clin Biol Res. 1988;260:613-20. Prog Clin Biol Res. 1988. PMID: 3283771 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters